Theme: Hormones for Healthy Mankind

Hormones 2016

Hormones 2016

With enthusiastic support of our Organizing Committee and Editorial Board Member, it’s my pleasure to welcome you to participate in the 2nd International Conference on Hormones and Endocrine Disorders as a continuum of our previous successful conference, in New Orleans, USA during June 27-29, 2016.

Track 1: Hormones & Steroids

Hormones are chemical messengers that have diverse chemical structures including eicosanoids, steroids, amino acids, peptides, and proteins that are secreted into the blood, which carries them to organs and tissues of the body to exert their functions. They are essential for every activity of life, including the processes of such as digestion, metabolism, respiration, tissue function, sensory perception, sleep, excretion, lactation, stress, growth and development, movement, reproduction, and mood. Many hormones, such as neurotransmitters, are active in more than one physical process.

Related conference: 

2nd Hormones and Endocrine Disorders Conference June 27-29, 2016 New Orleans, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;  20th annual meeting of the Society for Behavioral Neuroendocrinology, June 22- 25, 2016 Canada; ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 2: Growth Supplements

The body naturally produces growth hormone (HGH or simply GH) in the pituitary gland, and, as its name implies, it is responsible for cell growth and regeneration. Increasing muscle mass and bone density are impossible without GH, but it also plays a major role in maintaining the health of all human tissue, including that of the brain and other vital organs. When secreted, GH remains active in the bloodstream for only a few minutes, but this is enough time for the liver to convert it into growth factors, the most crucial of which is insulin-like growth factor-1, or IGF-1, which boasts a host of anabolic properties. Scientists began to harvest GH from the pituitary glands of cadavers in the 1950s, but didn’t synthesize the first HGH in laboratories until 1981, with its use as a performance-enhancing drug becoming popular shortly thereafter.

Related conference:

 2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29, 2016, USA; 8th Euro Global Diabetes Summit and Medicare Expo  July 14-16, 2016 Birmingham, UK; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE;  2nd Global Conference of the European Society of Contraception and Reproductive Health November 12-16, 2015, Switzerland; American Society for Reproductive Medicine Congress October 17-21, 2015 Baltimore, USA 22nd IFFS World Congress on Fertility September 21-25, 2016 India13th Congress of the European Federation of Sexology (EFS) May 25-28, 2016 CROATIA Reproductive Health November 12-16, 2015  Chicago, USA; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 3: Hormones and Infertility 

Infertility is defined as not being able to get pregnant despite having frequent, unprotected sex for at least a year for most people and six months in certain circumstances. Roughly 50% of the women evaluated for infertility progressed to treatment, and only a small proportion were treated with more advanced assisted reproductive technologies such as in vitro fertilization.

Related conference:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Polycystic Ovarian Syndrome Conference November 16-18, 2015, USA;  11th World Congress of the European Society of Gynecology (ESG), October 21-24 2015 Czech Republic; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada,  Association of Early Pregnancy Units November 3-4 2015  UK, National Cancer Research Institute Cancer Conference, November 1-4 2015 UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 4: Hormones in Women Health

Female hormones mainly include estrogen and progesterone. These hormones influences sex differentiation and are responsible for reproduction. These are prescribed by doctors to Women to treat problems such as delayed puberty, pregnancy, Reproduction, Menopause and other medical problems that cause the body to make very low amounts of testosterone. Menopause is characterized as happening 12 months after last menstrual period and imprints the end of menstrual cycles. The move generally has three sections: perimenopause, menopause, and postmenopause. Menopause can happen in your 40s or 50s, yet the normal age is 51 in the United States.

Related conference includes:

2nd International Conference on  Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; Polycystic Ovarian Syndrome Conference November 16-18, 2015, USA; Pregnancy Summit and Child Health August 29-31, 2016, Brazil; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Reproductive Health November 12-16, 2015  Chicago, USA; 11th World Congress of the European Society of Gynecology (ESG), October 21-24 2015 Czech Republic; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada,  Association of Early Pregnancy Units November 3-4 2015  UK, National Cancer Research Institute Cancer Conference, November 1-4 2015 UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 5 : Body Building Hormones

6 Hormones to control for advanced muscle building results. Muscle growth and fat loss, two key prerequisites to showcasing your stage-ready, beach-worthy body, are, in many respects, contingent upon the optimization of the big two bodybuilding hormones: growth hormone (GH) and testosterone (T)

Related conference:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29, 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

Track 6:  Cushing's disease

Overproduction of a pituitary gland hormone leads to an overactive adrenal gland. A similar condition called Cushing's syndrome may occur in people, particularly children, who take high doses of corticosteroid medications. It is a cause of Cushing's syndrome characterised by increased secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary (secondary hypercortisolism). This is most often as a result of a pituitary adenoma (specifically pituitary basophilism) or due to excess production of hypothalamus CRH (Corticotropin releasing hormone) (tertiary hypercortisolism/hypercorticism) that stimulates the synthesis of cortisol by the adrenal glands. Pituitary adenomas are responsible for 80% of endogenous Cushing's syndrome, when excluding Cushing's syndrome from exogenously administered corticosteroids.

Related conference:

2nd International Conference on Hormones and Endocrine Disorders June 27-29,2016;  2nd International Conference on Prostate Cancer and Treatment May 5-7 2016, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30 2016, USA; International Conference on Oral, Mouth and Throat Cancer August 18-20 2016, USA; 7th Global Summit on Cancer Therapy October 05-07 2015 UAE; 4th International Conference on Blood Malignancies and Treatment April 18-20 2016, UAE, National Cancer Research Institute Cancer Conference, November 1-4 2015 UK; The 2015 San Antonio Breast Cancer Symposium December 8-12, 2015 USA;  10th European Breast Cancer Conference (EBCC-10), March 9-11 2016  Netherlands; World Cancer Congress, October 31 – November 3 2016 France; 17th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism November 19-22 2016 Albaniap; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 7: Gigantism and Growth Hormone Disorders

Overproduction of growth hormone causes excessive growth. In children, the condition is called gigantism. In adults, it is called acromegaly. Growth hormone stimulates the growth of bones, muscles, and many internal organs. Excessive growth hormone, therefore, leads to abnormally robust growth of all of these tissues. Overproduction of growth hormone is almost always caused by a noncancerous (benign) pituitary tumor (adenoma). Certain rare tumors of the pancreas and lungs also can produce hormones that stimulate the pituitary to produce excessive amounts of growth hormone, with similar consequences.

Related conference:

2nd International conference on Hormones and Endocrine Disorders June 27-29, 2016; 12th Diabetes Meeting and Therapeutics Expo September 29-October 1, 2016 Canada; 6th Global Diabetes Summit and Medicare Expo November 02-04, 2015 UAE; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015 India; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05, 2015 Spain; 11th Asia Pacific Diabetes Conference and Expo July 11-13, 2016 Australia; 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension November 5-7 2016, Turkey; 86th Annual Meeting of the American Thyroid Association September 21-25 2016 Colorado; 3rd Steroid Research Congress 15-18 Nov 2015 USA; 85th Annual Meeting of the American Thyroid Association 21–25 September 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 8: Hypothyroidism and Hyperthyroidism

The thyroid gland does not produce enough thyroid hormone, leading to fatigue, constipation, dry skin, and depression. The underactive gland can cause slowed development in children. Some types of hypothyroidism are present at birth. Hypothyroidism can be treated with levothyroxine. The dose is adjusted according to symptoms and normalization of the thyroxine and TSH levels. Thyroid medication is safe in pregnancy. While a certain amount of dietary iodine is important, excessive amounts can worsen certain types of hypothyroidism.

Related conference:                          

2nd Hormones and Endocrine Disorders Conference June 27-29, 2016 New Orleans, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA; 15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;  20th annual meeting of the Society for Behavioral Neuroendocrinology, June 22- 25, 2016 Canada; ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal;  EndoBridge 15–18 October 2015, Turkey; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 9 : Multiple endocrine neoplasia I and II

These are rare, genetic conditions are passed down through families. They cause tumors of the parathyroid, adrenal, and thyroid glands, leading to overproduction of hormones. The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time. The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.

Related conference:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 10: Polycystic ovary syndrome

Overproduction of androgens interfere with the development of eggs and their release from the female ovaries. PCOS is a leading cause of infertility. Polycystic ovary syndrome is a problem in which a woman hormones are out of balance. It can cause problems with your periods and make it difficult to get pregnant. PCOS also may cause unwanted changes in the way you look. If it isn't treated, over time it can lead to serious health problems, such as diabetes and heart disease. Hormones are chemical messengers that trigger many different processes, including growth and energy production. Often, the job of one hormone is to signal the release of another hormone.

Related conference includes:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 2nd International Conference on Current Trends in Mass Spectrometry May 09-11 2016, USA; 4th International Conference and Exhibition on Biologics and Biosimilars; Asia Pacific Mass Spectrometry Congress October 10-12, 2016 Kuala Lumpur; 2nd International Conference and Expo on Bio pharmaceutics September 01-03, 2016 Brazil; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France; EndoBridge 15–18 October 2015, Turkey; 11th Asia Pacific Diabetes Conference and Expo July 11-13, 2016 Australia; 5th World Congress on Controversies to Consensus in DiabetesObesity and Hypertension November 5-7 2016, Turkey; 86th Annual Meeting of the American Thyroid Association September 21-25 2016Colorado; 85th Annual Meeting of the American Thyroid Association 21–25 September 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 11: Steroids and Cancer 

Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems. There are more than 100 different types of cancer. Each type of cancer is unique with its own causes, symptoms, and methods of treatment. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012. The top three, lung, prostate and colorectal cancers, contributed nearly 42% of all cancers (excluding non-melanoma skin cancer).Approximately 2% to 3% of women in the United States will develop cancer of the endometrium at some point during their lives.

Related conference:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

 

Track 12: Steroids in Sports

Drugs commonly referred to as steroids can be classified as anabolic (anabolic-androgenic) steroids or corticosteroids. Corticosteroids, such as cortisone or prednisone are drugs that doctors often prescribe to help control inflammation in the body. Corticosteroids are not the same as the anabolic steroids that are often linked with illegal use in sports. Non-medical use of anabolic steroids is illegal and banned by most major sports organizations. In January 2005, the Anabolic Steroid Control Act was amended with the Controlled Substance Act that added anabolic steroids and prohormones (a precursor to a hormone) to the list of controlled substances and makes possession of the substances a federal crime.

Related conference:                

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 13 : Corticosteroids

Corticosteroids, often known as steroids, are an anti-inflammatory medicine prescribed for a wide range of conditions. They're a man-made version of hormones normally produced by the adrenal glands (two small glands that sit on top of the kidneys). Longterm corticosteroids, hydrocortisone (Cortef) and cortisone, are produced by the outer portion of the adrenal gland known as the cortex (hence the name, corticosteroid). Birth control pills can also affect high blood pressure. Women taking birth control pills usually experience a small rise in systolic and diastolic blood pressures.

Systemic corticosteroids refer to corticosteroids that are given orally or by injection and distribute throughout the body. It does not include corticosteroids used in the eyes, ears, or nose, on the skin or that are inhaled, although small amounts of these corticosteroids can be absorbed into the body. Corticosteroids treatment is mainly used to reduce inflammation and suppress the immune system

Related conference:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

 

Track 14: Anabolic Steroids and Supplements

Anabolic steroids are synthetic (man-made) substances similar to male sex hormone, testosterone. The term “anabolic” means “growth”. Here, it refers to growth in muscle mass. Natural Steroids are performance enhancing substances which cause an increase in anabolic muscle mass and physical strength. Some common examples of anabolic steroids include Androstenedione, Dehydrochloromethyltestosterone (Turinabol), Methandienone (Dianabol), Methyltestosterone (Android), Nandrolone (Durabolin), Oxandrolone (Oxandrin), Oxymetholone (Anadrol), Stanozolol (Winstrol).

Anabolic steroids stimulate growth in tissues, especially bone and muscles. They also increase the production of RBCs (Red blood Cells). Anabolic steroids can be taken orally, are injectable or are used externally. Anabolic steroids are used in the treatment of many medical issues such as delayed puberty in boys, sexual dysfunction in men, breast cancer in women, weight loss in HIV, osteoporosis, anemia, endometriosis and other conditions involving hormonal imbalance.

Related conference includes:

2nd International Conference on Hormones and Endocrine Disorders Conference June 27-29 2016, USA; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

 

 

With enthusiastic support of our Organizing Committee and Editorial Board Member, its my pleasure to welcome you  to participate in the 2nd International Conference on Hormones and Endocrine Disorders as a continuum of our previous successful conference, in New Orleans, USA during June 27-29, 2016. 

Growing steadily from its founding days in 2007, Conferenceseries LLC has become an internationally renowned organization in accelerating scientific discoveries. Conferenceseries LLC have explored the length and the breadth of the continents by expanding to America, Europe, The Middle East, Asia Pacific and Australia by taking its innovative research topics to the highly competitive research platforms.

2nd International Conference on Hormones and Steroids will provide an opportunity to hear and meet Researchers, Practitioners, and business professionals to share expertise, foster collaborations and assess rising innovations across the world.  This will be equally informative for participants who attend this meeting as well as a for key opinion leaders who want to brush up on their knowledge outside their own area of specialization.

The forum of around 300 Scientists, Researchers, Business professionals and Students from all corners of the globe will come together to discuss about Hormones, related disorders & therapy and its market at 2nd Global Summit on Hormones and Steroids. Each session of the meeting will be included with expert lectures, posters and vibrant discussions on current topics related to Hormones like Neurohormone, Reproductive Health, Infertility, Cancer, Diabetes, Menopause, Steroids, Hormonal Imbalance, Hormone replacement therapy and more. Hormone Summit 2016 will also provide an opportunity for enthusiastic and talented young researchers and students to share their knowledge before eminent scientist gathering through Young Research Forum and Poster Competition. 

Why Hormones 2016

World Class Speakers and Fresh New Talent from across the Globe in Health Industry

Packed Schedule: Workshops, Multi-track Conference, Expo area and more...

Unbeatable Atmosphere: Hundreds of Great Professional Folks, After Parties and Networking

Get your share of a booming market by Participating at Hormones 2016 and give your business access to buyers and opportunities from throughout the world. Join your industry peers generating serious revenue and doing new business. Hormone Summit  2016 offers unparalleled business opportunities and access to new markets in Health Science.

When you leave New Orleans, you will be able to use newly acquired knowledge straight away at the bench or at the bedside.

 

 

Hormones 2016 conference will provide opportunities to share and learn progressed by international scientists and academicians. The conference will consist of plenary talks, invited talks, panel discussions, poster presentations and exhibitions, thus providing a unique opportunity for communication and collaboration between academia, industry and planners in the areas of health Science. This program provides three days of robust discussions on recent research and advancement in the field of endocrinology and metabolism This will be equally informative for participants who attend this meeting as well as a for key opinion leaders who want to brush up on their knowledge in/outside their own area of specialization.

Scope and Importance:

Generally, in endocrinology patients come to attention for only two reasons - because of excess hormone action or through its lack. Each has a number of possible causes. The pace of progress in endocrinology has always been dictated by the development of assays to measure the hormones. By and large, clinical endocrinology is limited to the measurement of hormone concentrations in venous serum or body fluids such as urine or saliva.

A lack of hormone effect may result from a lack of the hormone however caused (e.g. genetic deletion, damage to the endocrine gland, lack of a synthetic enzyme) or from the production of a biologically inactive hormone. The hormone receptor (or the down-stream signalling pathways) may be structurally abnormal and inactive leading to hormone resistance.

Market Analysis:

The global markets for hormonal drugs are divided into segments such as hormone relacement therapy market, diabetes market, growth hormone market, and hypogonadism market.

The three major segments of the hormone replacement therapy market are Estrogen replacement therapy, growth hormone replacement market and thyroid hormone replacement therapy. The largest market share is taken by estrogen replacement therapy administered to post menopausal women. It is followed by growth hormone and thyroid hormone replacement therapies in children and the elderly. 

The global hormone replacement therapy market is expected to rise to approximately USD 3.6 billion by 2018. Also it is forecast that the CAGR will be 2.5%. The estrogen administration segment is expected to be the largest in this market with a CAGR of 2.8%. 

The major holdback of the hormone replacement therapy market is the pricing pressure. An average estrogen replacement therapy will cost USD 10,000 per annum to a patient. Thus it is quite evident that this treatment is still not accessible to middle class consumers, especially those of developing nations. The major market for hormone replacement therapy is North America and other developed nations spread worldwide owing to the high purchasing power of the patients and growing awareness.

The major market players in the hormone replacement therapy market are Pfizer, Merck & co., BioSante Pharmaceuticals and Amgen. The other key players being Depomed Inc., QuatRx Pharmaceuticals, Noven Pharmaceuticals etc.

The market for diabetes is experiencing tremendous growth under the influence of rapidly increasing prevalence of diabetes worldwide. According to statistics of International Diabetes Foundation (IDF), in 2013, the global population diagnosed with diabetes was around 355 million, and is anticipated to grow to reach 592 million by the end of 2035. Such rapid prevalence of diabetes fuels the growth of diabetes market. Inception of new drug delivery for growth hormone and rising cases of end stage renal disease (ESRD), cancer, along with rise in disposable income are factors that drive the market for human growth hormone. On the other hand off label uses of human growth hormone (HGH) for body building, anti-aging and in sports are posing a challenge to the society not only because it is illegal but also because use of human growth hormone (HGH) is associated with high risk and side effects.

Hypogonadism market comprises testosterone, estrogen and progesterone replacement therapy market. This segment will experience the growth due to increasing awareness about post-menopausal hazards amongst women, awareness about testosterone amongst men. Extensive R&D is another important factor that propels growth of the market. As of 2013, there are around 180 new formulations under pipeline studies to treat diabetes, out of which, around 13 are waiting for approval from regulatory bodies. 

Steroids Summit-2015

 

The Global Summit on Steroids hosted by the OMICS International was held on July 13-15, 2015 at Double Tree by Hilton Baltimore, USA. Generous response and active participation were received from the Editorial Board Members of OMICS Group Journal- Journal of Steroids & Hormonal Science, Journal of Endocrinology & Metabolic Syndrome and Journal of Women Health and Care as well as from scientists, researchers and leaders who made this conference as one of the most successful and productive events in 2015 from OMICS Group International. 

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:

  • Recent Research and Advances in Steroids
  • Steroids as Hormones
  • Neurosteroids
  • Steroids Activity
  • Women Health
  • Steroids and Infertility
  • Steroids in Perinatal Medicine
  • Cancer
  • Anabolic Androgenic Steroids
  • Corticosteroids
  • Steroid Therapy and Effects
  • Steroids Determination

The conference was initiated with a series of lectures delivered by both Honorable Guestsand members of the Keynote forum. Keynote includes expert presentation by Dr. G E Hoffman, Professor at Morgan State University, USA; Professor John N Stallone, Texas A&M University, USA .  The Organizing Committee would like to thank the moderators Ladislav Vyklický, Institute of Physiology, Czech Republic and Michael L. McCaskill, Tulane University School of Public Health and Tropical Medicine, USA, for their contributions which resulted in smooth functioning of the conference.

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Steroids and Hormonal Science as a special issue. 

We are also obliged to various outside experts, physicians and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Steroids Summit 2015, and with their unique feedback, OMICS Group would like to announce the "2nd International Conference on Hormones and Endocrine Disorders "to be held in New Orleans, USA during June 27-29, 2016.

Hoping to see you again, with added vigor and with your other colleagues who will be interested in Hormones and Steroids 2016.

 


Past Reports  Proceedings  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 27-29, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations